MetLife Investment Management’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171K | Hold |
27,337
| – | – | ﹤0.01% | 2268 |
|
|
2025
Q1 | $160K | Sell |
27,337
-448
| -2% | -$2.63K | ﹤0.01% | 2309 |
|
|
2024
Q4 | $228K | Hold |
27,785
| – | – | ﹤0.01% | 2239 |
|
|
2024
Q3 | $248K | Hold |
27,785
| – | – | ﹤0.01% | 2172 |
|
|
2024
Q2 | $210K | Buy |
27,785
+11,076
| +66% | +$83.7K | ﹤0.01% | 2209 |
|
|
2024
Q1 | $131K | Buy |
16,709
+1,733
| +12% | +$13.6K | ﹤0.01% | 2413 |
|
|
2023
Q4 | $133K | Hold |
14,976
| – | – | ﹤0.01% | 2468 |
|
|
2023
Q3 | $134K | Hold |
14,976
| – | – | ﹤0.01% | 2428 |
|
|
2023
Q2 | $185K | Buy |
14,976
+3,950
| +36% | +$48.8K | ﹤0.01% | 2331 |
|
|
2023
Q1 | $102K | Hold |
11,026
| – | – | ﹤0.01% | 2544 |
|
|
2022
Q4 | $116K | Hold |
11,026
| – | – | ﹤0.01% | 2533 |
|
|
2022
Q3 | $200K | Hold |
11,026
| – | – | ﹤0.01% | 2306 |
|
|
2022
Q2 | $156K | Buy |
+11,026
| New | +$156K | ﹤0.01% | 2470 |
|